Zimmer Biomet Holdings, Inc. (ZBH)
USD 105.86
(-2.04%)
USD 105.86
(-2.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.27 Billion USD | 30.34% |
| 2022 | 1.06 Billion USD | 23.69% |
| 2021 | 860.3 Million USD | 18.94% |
| 2020 | 723.3 Million USD | -36.41% |
| 2019 | 1.13 Billion USD | 3265.38% |
| 2018 | 33.8 Million USD | -95.89% |
| 2017 | 823.2 Million USD | -0.57% |
| 2016 | 827.9 Million USD | 153.65% |
| 2015 | 326.4 Million USD | -68.45% |
| 2014 | 1.03 Billion USD | -0.09% |
| 2013 | 1.03 Billion USD | -1.13% |
| 2012 | 1.04 Billion USD | 2.28% |
| 2011 | 1.02 Billion USD | 11.72% |
| 2010 | 916.7 Million USD | -10.02% |
| 2009 | 1.01 Billion USD | -6.53% |
| 2008 | 1.09 Billion USD | -3.33% |
| 2007 | 1.12 Billion USD | -3.23% |
| 2006 | 1.16 Billion USD | 10.45% |
| 2005 | 1.05 Billion USD | 38.23% |
| 2004 | 763.2 Million USD | 69.34% |
| 2003 | 450.7 Million USD | 12.42% |
| 2002 | 400.9 Million USD | 61.46% |
| 2001 | 248.3 Million USD | -7.35% |
| 2000 | 268 Million USD | 16.02% |
| 1999 | 231 Million USD | 9.48% |
| 1998 | 211 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 335.5 Million USD | 2.82% |
| 2024 Q3 | 279.5 Million USD | -16.69% |
| 2024 Q1 | 326.3 Million USD | -24.94% |
| 2023 Q4 | 434.7 Million USD | 63.05% |
| 2023 Q2 | 329.6 Million USD | 0.7% |
| 2023 Q1 | 327.3 Million USD | 1.36% |
| 2023 Q3 | 266.6 Million USD | -19.11% |
| 2023 FY | 1.38 Billion USD | 30.34% |
| 2022 FY | 1.06 Billion USD | 23.69% |
| 2022 Q2 | 280.9 Million USD | 41.58% |
| 2022 Q1 | 198.4 Million USD | 48.28% |
| 2022 Q3 | 245.3 Million USD | -12.67% |
| 2022 Q4 | 322.9 Million USD | 31.63% |
| 2021 Q2 | 220.5 Million USD | -16.98% |
| 2021 Q3 | 214.9 Million USD | -2.54% |
| 2021 Q1 | 265.6 Million USD | 10.34% |
| 2021 Q4 | 133.8 Million USD | -37.74% |
| 2021 FY | 860.3 Million USD | 18.94% |
| 2020 Q3 | 299.2 Million USD | 274.26% |
| 2020 Q1 | -456 Million USD | -235.39% |
| 2020 Q2 | -171.7 Million USD | 62.35% |
| 2020 Q4 | 240.7 Million USD | -19.55% |
| 2020 FY | 723.3 Million USD | -36.41% |
| 2019 FY | 1.13 Billion USD | 3265.38% |
| 2019 Q1 | 350.2 Million USD | 144.3% |
| 2019 Q2 | 204.7 Million USD | -41.55% |
| 2019 Q3 | 245.8 Million USD | 20.08% |
| 2019 Q4 | 336.8 Million USD | 37.02% |
| 2018 Q4 | -790.5 Million USD | -454.01% |
| 2018 FY | 33.8 Million USD | -95.89% |
| 2018 Q1 | 305 Million USD | 1431.88% |
| 2018 Q2 | 296 Million USD | -2.95% |
| 2018 Q3 | 223.3 Million USD | -24.56% |
| 2017 Q2 | 282.3 Million USD | -19.43% |
| 2017 FY | 823.2 Million USD | -0.57% |
| 2017 Q4 | -22.9 Million USD | -110.73% |
| 2017 Q3 | 213.4 Million USD | -24.41% |
| 2017 Q1 | 350.4 Million USD | 89.1% |
| 2016 Q2 | 201.6 Million USD | -17.88% |
| 2016 Q3 | 195.5 Million USD | -3.03% |
| 2016 Q4 | 185.3 Million USD | -5.22% |
| 2016 FY | 827.9 Million USD | 153.65% |
| 2016 Q1 | 245.5 Million USD | 14.99% |
| 2015 Q4 | 213.5 Million USD | 84.05% |
| 2015 Q1 | 274.9 Million USD | 21.74% |
| 2015 Q3 | 116 Million USD | 189.58% |
| 2015 FY | 326.4 Million USD | -68.45% |
| 2015 Q2 | -129.5 Million USD | -147.11% |
| 2014 Q4 | 225.8 Million USD | -10.11% |
| 2014 FY | 1.03 Billion USD | -0.09% |
| 2014 Q3 | 251.2 Million USD | -3.12% |
| 2014 Q2 | 259.3 Million USD | -13.1% |
| 2014 Q1 | 298.4 Million USD | -5.36% |
| 2013 Q2 | 210.4 Million USD | -29.44% |
| 2013 Q1 | 298.2 Million USD | 48.73% |
| 2013 Q4 | 315.3 Million USD | 48.94% |
| 2013 Q3 | 211.7 Million USD | 0.62% |
| 2013 FY | 1.03 Billion USD | -1.13% |
| 2012 FY | 1.04 Billion USD | 2.28% |
| 2012 Q3 | 249.4 Million USD | -17.39% |
| 2012 Q2 | 301.9 Million USD | 2.13% |
| 2012 Q1 | 295.6 Million USD | 46.92% |
| 2012 Q4 | 200.5 Million USD | -19.61% |
| 2011 Q1 | 297.2 Million USD | 141.82% |
| 2011 FY | 1.02 Billion USD | 11.72% |
| 2011 Q4 | 201.2 Million USD | -24.53% |
| 2011 Q3 | 266.6 Million USD | 2.89% |
| 2011 Q2 | 259.1 Million USD | -12.82% |
| 2010 Q3 | 271.6 Million USD | 19.07% |
| 2010 Q1 | 294.1 Million USD | 23.31% |
| 2010 Q2 | 228.1 Million USD | -22.44% |
| 2010 FY | 916.7 Million USD | -10.02% |
| 2010 Q4 | 122.9 Million USD | -54.75% |
| 2009 Q1 | 279.8 Million USD | 16.73% |
| 2009 FY | 1.01 Billion USD | -6.53% |
| 2009 Q4 | 238.5 Million USD | 16.91% |
| 2009 Q3 | 204 Million USD | -31.2% |
| 2009 Q2 | 296.5 Million USD | 5.97% |
| 2008 Q1 | 331.6 Million USD | -5.77% |
| 2008 Q2 | 308.4 Million USD | -7.0% |
| 2008 Q4 | 239.7 Million USD | 13.98% |
| 2008 Q3 | 210.3 Million USD | -31.81% |
| 2008 FY | 1.09 Billion USD | -3.33% |
| 2007 Q2 | 322.5 Million USD | -1.44% |
| 2007 Q3 | 126 Million USD | -60.93% |
| 2007 FY | 1.12 Billion USD | -3.23% |
| 2007 Q1 | 327.2 Million USD | -3.28% |
| 2007 Q4 | 351.9 Million USD | 179.29% |
| 2006 Q4 | 338.3 Million USD | 32.93% |
| 2006 FY | 1.16 Billion USD | 10.45% |
| 2006 Q3 | 254.5 Million USD | -9.72% |
| 2006 Q1 | 290.5 Million USD | 3.38% |
| 2006 Q2 | 281.9 Million USD | -2.96% |
| 2005 FY | 1.05 Billion USD | 38.23% |
| 2005 Q1 | 257.6 Million USD | 6.62% |
| 2005 Q2 | 275.8 Million USD | 7.07% |
| 2005 Q3 | 240.6 Million USD | -12.76% |
| 2005 Q4 | 281 Million USD | 16.79% |
| 2004 Q1 | 153.8 Million USD | 134.81% |
| 2004 Q3 | 192 Million USD | 9.22% |
| 2004 Q2 | 175.8 Million USD | 14.3% |
| 2004 FY | 763.2 Million USD | 69.34% |
| 2004 Q4 | 241.6 Million USD | 25.83% |
| 2003 Q2 | 134.7 Million USD | 10.41% |
| 2003 FY | 450.7 Million USD | 12.42% |
| 2003 Q3 | 128.5 Million USD | -4.6% |
| 2003 Q1 | 122 Million USD | 9.81% |
| 2003 Q4 | 65.5 Million USD | -49.03% |
| 2002 Q4 | 111.1 Million USD | 13.25% |
| 2002 FY | 400.9 Million USD | 61.46% |
| 2002 Q1 | 88.3 Million USD | 22.64% |
| 2002 Q2 | 103.4 Million USD | 17.1% |
| 2002 Q3 | 98.1 Million USD | -5.13% |
| 2001 Q3 | 50.8 Million USD | -26.27% |
| 2001 FY | 248.3 Million USD | -7.35% |
| 2001 Q2 | 68.9 Million USD | 21.73% |
| 2001 Q1 | 56.6 Million USD | -21.82% |
| 2001 Q4 | 72 Million USD | 41.73% |
| 2000 Q2 | 71.9 Million USD | 22.28% |
| 2000 Q1 | 58.8 Million USD | 0.0% |
| 2000 FY | 268 Million USD | 16.02% |
| 2000 Q4 | 72.4 Million USD | 11.56% |
| 2000 Q3 | 64.9 Million USD | -9.74% |
| 1999 FY | 231 Million USD | 9.48% |
| 1998 FY | 211 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 80.276% |
| Allurion Technologies Inc. | -78.07 Million USD | 1736.44% |
| Artivion, Inc. | 5.74 Million USD | -22151.829% |
| Avanos Medical, Inc. | 4.2 Million USD | -30321.429% |
| Butterfly Network, Inc. | -145.61 Million USD | 977.481% |
| Butterfly Network, Inc. | -145.61 Million USD | 977.481% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | -232.911% |
| Boston Scientific Corporation | 2.34 Billion USD | 45.467% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | 8515.887% |
| CONMED Corporation | 130.78 Million USD | -876.939% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 16.713% |
| Paragon 28, Inc. | -37.3 Million USD | 3524.643% |
| Glaukos Corporation | -128.7 Million USD | 1092.774% |
| Globus Medical, Inc. | 133.14 Million USD | -859.652% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | 3272.755% |
| Integer Holdings Corporation | 167.33 Million USD | -663.581% |
| Medtronic plc | 5.14 Billion USD | 75.161% |
| Nevro Corp. | -99.3 Million USD | 1386.603% |
| Owlet, Inc. | -28.63 Million USD | 4562.49% |
| Penumbra, Inc. | 73.55 Million USD | -1637.162% |
| Vicarious Surgical Inc. | -80.66 Million USD | 1683.939% |
| Smith & Nephew plc | 425 Million USD | -200.635% |
| Sonendo, Inc. | -57.74 Million USD | 2312.736% |
| STERIS plc | 836.11 Million USD | -52.813% |
| Stryker Corporation | 3.88 Billion USD | 67.137% |
| Vapotherm, Inc. | -39.08 Million USD | 3369.447% |